"Verapamil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A calcium channel blocker that is a class IV anti-arrhythmia agent.
Descriptor ID |
D014700
|
MeSH Number(s) |
D02.092.471.683.953
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Verapamil".
Below are MeSH descriptors whose meaning is more specific than "Verapamil".
This graph shows the total number of publications written about "Verapamil" by people in this website by year, and whether "Verapamil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2009 | 0 | 2 | 2 |
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Verapamil" by people in Profiles.
-
Basilar artery occlusion in a child treated successfully with mechanical thrombectomy using ADAPT. BMJ Case Rep. 2016 Apr 11; 2016.
-
In vivo and ex vivo evaluation of L-type calcium channel blockers on acid beta-glucosidase in Gaucher disease mouse models. PLoS One. 2009 Oct 07; 4(10):e7320.
-
The no-reflow phenomenon in the coronary circulation. Cardiovasc Hematol Agents Med Chem. 2009 Jul; 7(3):181-92.
-
Verapamil toxicity: an unusual case report and review of the literature. Am J Forensic Med Pathol. 2007 Jun; 28(2):137-40.
-
The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens (Greenwich). 2004 Nov; 6(11):621-29; quiz 630-1.
-
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003 Nov 05; 42(9):1687-713.
-
Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein. Int J Oncol. 2000 Sep; 17(3):579-86.
-
Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains. J Biol Chem. 1998 Apr 24; 273(17):10132-8.
-
Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins. Cancer. 1995 May 15; 75(10):2597-604.
-
Characterization of a human myeloid leukemia cell line highly resistant to taxol. Leukemia. 1994 Mar; 8(3):465-75.